S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Fund/BVF Partners/Q4 2020

BVF Partners

Periodo: Q4 2020 · Depositato: 2021-02-12
Vedi su SEC EDGAR
AUM
$2.54B
Valore totale del portafoglio
Posizioni
68
Titoli dichiarati
Prima Posizione
OLMA
12.6% $320.3M
Var. Trimestrali
+8 / -8
nuovi · usciti
⚠️Informativa sui Depositi 13F

I dati AUM mostrati sono calcolati sommando il valore di mercato dichiarato di tutte le posizioni nei depositi SEC 13F-HR — non rappresentano il patrimonio effettivo gestito dal fondo.

  • Escluse liquidità, obbligazioni, private equity, posizioni corte e azioni estere non soggette all'obbligo di dichiarazione.
  • Per le opzioni PUT e CALL, il Valore dichiarato è il valore nozionale delle azioni sottostanti — non il premio pagato. Ciò sovrastima significativamente il capitale effettivamente a rischio.
  • Il patrimonio reale del fondo è tipicamente superiore e include strategie, strumenti e posizioni che non compaiono mai in un 13F.
  • I depositi 13F riguardano i gestori istituzionali con ≥$100M in titoli 13F. Le posizioni riflettono le partecipazioni a fine trimestre, divulgate entro 45 giorni dalla fine del periodo.

Dati provenienti da SEC EDGAR. Questo tracker è a scopo puramente informativo e non costituisce consulenza finanziaria.

Partecipazioni in Portafoglio

Prime 30 posizioni

⚠️ Performance % calcolata dalla data di deposito ( 2021-02-12) si riferisce al titolo sottostante — non al P&L del derivato.
TickerEmittenteNozionalePortafoglio %Al DepositoOra (Fine Giornata)Dal DepositoAllocazione
OLMAOLEMA PHARMACEUTICALS INC$320.3M12.60%$48.08$12.64-73.7%
12.6%
XOMAXOMA CORP DEL$184.6M7.26%$44.13$43.00-2.6%
7.3%
KYMRKYMERA THERAPEUTICS INC$163.1M6.42%$62.00$113.51+83.1%
6.4%
RLAYRELAY THERAPEUTICS INC$127.7M5.02%$41.56$18.65-55.1%
5.0%
RVMDREVOLUTION MEDICINES INC$109.6M4.31%$39.59$189.24+378.0%
4.3%
RPTXREPARE THERAPEUTICS INC$102.0M4.01%
4.0%
MRUSMERUS N V$101.8M4.00%
4.0%
CYTKCYTOKINETICS INC$101.4M3.99%$20.78$86.49+316.2%
4.0%
PTGXPROTAGONIST THERAPEUTICS INC$86.2M3.39%$20.16$131.62+552.9%
3.4%
IONSIONIS PHARMACEUTICALS INC$77.2M3.03%$56.54$81.80+44.7%
3.0%
RCUSARCUS BIOSCIENCES INC$71.5M2.81%$25.96$30.33+16.8%
2.8%
XNCRXENCOR INC$55.2M2.17%$43.63$15.00-65.6%
2.2%
XENEXENON PHARMACEUTICALS INC$53.8M2.12%$15.38$60.96+296.4%
2.1%
AMRNXXXXAMARIN CORP PLC$52.6M2.07%
2.1%
ACIUAC IMMUNE SA$50.8M2.00%$5.17$2.51-51.5%
2.0%
ALXOALX ONCOLOGY HLDGS INC$46.6M1.83%$86.20$2.07-97.6%
1.8%
FDMT4D MOLECULAR THERAPEUTICS IN$45.9M1.80%$41.45$13.00-68.6%
1.8%
IDYAIDEAYA BIOSCIENCES INC$45.2M1.78%$14.00$37.65+168.9%
1.8%
EPIXESSA PHARMA INC$44.2M1.74%
1.7%
SPROSPERO THERAPEUTICS INC$43.5M1.71%$19.39$2.20-88.7%
1.7%
KURAKURA ONCOLOGY INC$40.7M1.60%$32.66$11.10-66.0%
1.6%
STROSUTRO BIOPHARMA INC$40.3M1.58%$217.10$30.43-86.0%
1.6%
LXRXLEXICON PHARMACEUTICALS INC$37.5M1.47%$3.42$2.32-32.2%
1.5%
INFIQINFINITY PHARMACEUTICALS INC$36.9M1.45%$2.12$0.00
1.4%
CTMXCYTOMX THERAPEUTICS INC$36.5M1.44%$6.55$3.82-41.7%
1.4%
GLYCGLYCOMIMETICS INC$35.9M1.41%
1.4%
FBRXFORTE BIOSCIENCES INC$26.2M1.03%$910.25$20.92-97.7%
1.0%
CALTCALLIDITAS THERAPEUTICS AB$25.5M1.00%
1.0%
VSTMXXXXVERASTEM INC$23.8M0.94%
0.9%
IMVTIMMUNOVANT INC$23.8M0.93%$46.19$38.79-16.0%
0.9%

Attività Trimestre su Trimestre

Q4 2020 vs. Q3 2020

Nuove Posizioni (8)

TickerEmittenteNozionaleDal Deposito
OLMAOLEMA PHARMACEUTICALS INC$320.3M-73.7%
FDMT4D MOLECULAR THERAPEUTICS IN$45.9M-68.6%
LXRXLEXICON PHARMACEUTICALS INC$37.5M-32.2%
COGTCOGENT BIOSCIENCES INC$17.2M
NVUSNOVUS THERAPEUTICS INC$11.8M
GRTSQGRITSTONE ONCOLOGY INC$10.6M
EUCRUEUCRATES BIOMEDICAL ACQU COR$5.3M
FLACUFRAZIER LIFESCIENCES ACQU CO$5.2M

Posizioni Chiuse (8)

TickerEmittenteNozionale
CLDXCELLDEX THERAPEUTICS INC NEW$45.5M
REPLREPLIMUNE GROUP INC$39.0M
ANABANAPTYSBIO INC$18.1M
EVLOEVELO BIOSCIENCES INC$6.8M
NVUSNOVUS THERAPEUTICS INC$3.3M
BLRXBIOLINERX LTD$2.8M
SBPHSPRING BK PHARMACEUTICALS IN$1.3M
EXELEXELIXIS INC$0.4M

Aumentate (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
AMRNXXXXAMARIN CORP PLC$48.0M+878.3%
IONSIONIS PHARMACEUTICALS INC$42.3M+85.6%+44.7%
PTGXPROTAGONIST THERAPEUTICS INC$39.8M+80.1%+552.9%
SPROSPERO THERAPEUTICS INC$28.5M+66.9%-88.7%
CTMXCYTOMX THERAPEUTICS INC$12.8M+56.7%-41.7%
CYTKCYTOKINETICS INC$29.4M+46.8%+316.2%
RVMDREVOLUTION MEDICINES INC$36.5M+31.7%+378.0%
GLYCGLYCOMIMETICS INC$13.7M+31.7%

Ridotte (8)

TickerEmittenteNozionaleVar. AzioniDal Deposito
SWTXSPRINGWORKS THERAPEUTICS INC$-97.9M-100.0%
PANAUPANACEA ACQUISITION CORP$-9.5M-98.8%
FPRXFIVE PRIME THERAPEUTICS INC$-20.0M-87.0%
CRISCURIS INC$0.9M-82.8%
SNDXSYNDAX PHARMACEUTICALS INC$-16.9M-64.4%
ARGXARGENX SE$-26.1M-63.2%
RNACSELECTA BIOSCIENCES INC$-11.0M-60.9%
IMVTIMMUNOVANT INC$-18.4M-57.1%-16.0%
Torna agli Hedge Fund